Dr Reddys Laboratories (RDY) Other Working Capital Changes (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Other Working Capital Changes of -$3.2 million in Q3 2025, up 91.98% quarter-over-quarter from -$40.2 million in Q2 2025, and up 71.98% on a YoY basis from -$1.9 million in Q3 2024.

Dr Reddys Laboratories (RDY) Other Working Capital Changes (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$3.2 million for Q3 2025.

  • In Q3 2025, Other Working Capital Changes rose 71.98% year-over-year to -$3.2 million; the TTM figure through Sep 2025 stood at -$156.9 million (changed N/A YoY), while the FY2026 annual figure was $10.2 million, up 111.78% from the prior year.
  • Other Working Capital Changes was -$3.2 million for Q3 2025 at Dr Reddys Laboratories, up from -$40.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of -$3.2 million in Q3 2025 to a low of -$102.0 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -3.22 Mn
Sep 30, 2025 -3.22 Mn
Jun 30, 2025 -40.16 Mn
Jun 30, 2025 -40.16 Mn
Sep 30, 2024 -11.50 Mn
Sep 30, 2024 -11.50 Mn
Jun 30, 2024 -102.03 Mn
Jun 30, 2024 -102.03 Mn